Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial is evaluating how long calaspargase pegol maintains active asparaginase levels in pediatric patients. The study targets c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asparlas (calaspargase pegol)

Snippet

Sponsor: Mayo Clinic | Conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Lymphoblastic Lymphoma | Status: NOT_YET_RECRUITING